AR003003A1 - Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo. - Google Patents

Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.

Info

Publication number
AR003003A1
AR003003A1 ARP960102975A AR10297596A AR003003A1 AR 003003 A1 AR003003 A1 AR 003003A1 AR P960102975 A ARP960102975 A AR P960102975A AR 10297596 A AR10297596 A AR 10297596A AR 003003 A1 AR003003 A1 AR 003003A1
Authority
AR
Argentina
Prior art keywords
virus
marek
cultivating
vaccine
protection
Prior art date
Application number
ARP960102975A
Other languages
English (en)
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of AR003003A1 publication Critical patent/AR003003A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención está relacionada con el virus de la enfermedad de Marek adaptado para ser cultivado sobre una línea celular avícola contínua, enparticular sobre la línea celular de codorniz QT-35, con la proliferación de los virus asíadaptados sobre cultivos celulares avícolas contínuos, y convacunas que contienen estos virus.
ARP960102975A 1995-06-12 1996-06-06 Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo. AR003003A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201540 1995-06-12

Publications (1)

Publication Number Publication Date
AR003003A1 true AR003003A1 (es) 1998-05-27

Family

ID=8220371

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102975A AR003003A1 (es) 1995-06-12 1996-06-06 Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.

Country Status (13)

Country Link
US (1) US5789231A (es)
EP (1) EP0748867A1 (es)
JP (1) JPH0998778A (es)
CN (1) CN1147015A (es)
AR (1) AR003003A1 (es)
AU (1) AU5240896A (es)
BR (1) BR9602719A (es)
CA (1) CA2178553A1 (es)
HU (1) HUP9601608A2 (es)
IL (1) IL118613A0 (es)
MX (1) MX9602256A (es)
TR (1) TR199600502A1 (es)
ZA (1) ZA964878B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0884382A3 (en) * 1997-06-10 2000-10-25 Pfizer Products Inc. Processes for preparation of marek's disease virus using continuous mammalian cell lines
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
CN1688335A (zh) * 2002-02-06 2005-10-26 洛曼动物健康两合公司 生产疫苗的连续细胞系
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
US20070111211A1 (en) * 2003-12-30 2007-05-17 Virumar Pituach Tarkivim Ltd. Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
US20070178115A1 (en) 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines
JP5653223B2 (ja) * 2008-02-25 2015-01-14 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 連続細胞系の生成方法
CN121472137B (zh) * 2026-01-12 2026-04-07 北京市农林科学院 鸽成纤维细胞株x4及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US4071618A (en) * 1974-09-03 1978-01-31 Research Foundation For Microbial Diseases Of Osaka University Process for preparing virus disease live vaccines
DE3064175D1 (en) * 1979-02-06 1983-08-25 Sigmund Stokland Harvester-thresher
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Also Published As

Publication number Publication date
CN1147015A (zh) 1997-04-09
BR9602719A (pt) 1998-04-22
HUP9601608A2 (en) 1997-03-28
AU5240896A (en) 1997-01-02
ZA964878B (en) 1997-01-07
US5789231A (en) 1998-08-04
EP0748867A1 (en) 1996-12-18
MX9602256A (es) 1997-01-31
TR199600502A1 (tr) 1996-12-21
HU9601608D0 (en) 1996-07-29
CA2178553A1 (en) 1996-12-13
IL118613A0 (en) 1996-10-16
JPH0998778A (ja) 1997-04-15

Similar Documents

Publication Publication Date Title
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
ES2098029T5 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
GB2199328B (en) Use of a 5' untranslated leader sequence of an rna virus to enhance translation
DE69625802D1 (de) Impfstoffe gegen die pest
ES2152304T3 (es) Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.
BR9106374A (pt) Vacina oral e processo de extrair uma imunoresponsta em um mamifero
AR003003A1 (es) Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.
CO4940430A1 (es) Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ES2058237T3 (es) Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
ES2061165T3 (es) Vacuna para la proteccion de las aves de corral frente a la enfermedad de marek.
BR9905779A (pt) Processos para preparação do vìrus da doença de marek utilizando linhagens de células contìnuas de aves
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
BR9706133A (pt) Mycoplasma synoviae atenuado vivo cultura microbiológica vacina para a proteção de aves domésticas processo para sua preparação e uso da cepa mycoplasma synoviae
AR007611A1 (es) Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek
DE69417717D1 (de) Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen
KR880002998A (ko) 가금류의 대장균증 백신
ES2062502T3 (es) Una proteina de factor i pura y un procedimiento para obtener dicha proteina.
ES2139549A1 (es) Vacuna anti-flexibacter maritimus (fm-95) para la prevencion de la enfermedad "flexibacteriosis marina" en rodaballo y peces salmonidos, y procedimiento de obtencion.
PT783319E (pt) Composicoes de peptidos de muramilo que inibem a replicacao do hiv
ES2115550B1 (es) Vacuna anti-pasteurella piscicida (di)para la prevencion de la enfermedad pasteurelosis en dorada y lubina y procedimiento de obtencion. .
NZ333213A (en) Modified live avian polyomavirus vaccine in psittaciformes